KIR3DL1 and leukemia: The beneficial effect of a KIR-ligand mismatch became clear from animal- and human studies showing an NK mediated improved clinical outcome in leukemia patients upon haploidentical stem cell transplantation when KIR-ligand mismatched donors were selected [25].